Development and pilot evaluation of an evidence-based algorithm for MASLD (formerly NAFLD) management in primary care in Europe

BackgroundMetabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD), emerges as major cause of morbidity and mortality globally, with chronic patients facing increased risk. Guidelines on MASLD management in primary care (PC) are limited. This study aimed to develop and evalua...

Full description

Bibliographic Details

Published in:	Frontiers in Medicine
Main Authors:	Marilena Anastasaki, Sophia Papadakis, Irini N. Gergianaki, Loucas Papastamatiou, Eftychios Aligizakis, Nikoleta Grillaki, Eleni Boutzoukaki, Nektarios Sivaropoulos, Foteini Anastasiou, Juan Mendive, Carlos de Juan-Asenjo, Rosario Hernández-Ibáñez, Alba Martínez-Escudé, Montserrat Garcia-Retortillo, Ger Koek, Leen Heyens, Jean Muris, Christos D. Lionis
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-11-01
Subjects:	metabolic dysfunction-associated steatotic liver disease (MASLD) primary care clinical care pathways risk classification non-alcoholic fatty liver disease (NAFLD) screening
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2024.1383112/full